Gufic BioScience
GUFICBIO • Pharmaceuticals & Biotechnology
Last Price
₹407.35
Market Cap
₹4.09K Cr
Sector
Pharmaceuticals & Biotechnology
For educational/research use only. Not a recommendation to buy or sell.
At a glance
as of 2026-10-26Sector: Gufic BioScience (GUFICBIO) is an NSE-listed company in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry. NSE sector rotation chart
Sharia rating: Gufic BioScience is rated Halal by a specialist third-party provider. Full list of halal NSE stocks
9% below its 52-week high
Price trend
Positive
Over the last 6 months, Gufic BioScience's share price has risen, doing better than 76% of Pharmaceuticals & Biotechnology stocks. It is trading above its 200-day average price.
Institutional activity
Neutral
Trading patterns over recent weeks show no clear sign of institutions buying or selling Gufic BioScience (buying score 1/10, selling score 2/10).
Model rank
Negative
Our model's 5-day return score puts Gufic BioScience ahead of 36% of NSE stocks. The model has low confidence in this score (28%).
Ease of trading
Low
Shares change hands easily; there are no signs of trading drying up (risk score 1/10). Delivery-based buying has been falling while the price has held up.
Price vs profits
Well above typical
The share price is 61× last year's profit per share — well above the typical range for NSE stocks (15–30×).
The wider Indian market is in a crisis regime — unusually sharp moves (model 100% sure). This affects every stock's model rank.
Browse ready-made screens →Company Information
About Gufic BioScience (GUFICBIO)
Gufic BioScience is an NSE-listed company operating in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry (ISIN INE742B01025). This page brings together the quantitative research signals our models compute for GUFICBIO: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.
To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Gufic BioScience's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.
The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.